Ignite Creation Date:
2025-12-24 @ 12:55 PM
Ignite Modification Date:
2025-12-28 @ 12:32 PM
Study NCT ID:
NCT06173661
Status:
RECRUITING
Last Update Posted:
2025-09-23
First Post:
2023-11-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
Sponsor:
Brigham and Women's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-28
First Submit QC Date:
None
Study First Post Date:
2023-12-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-19
Last Update Post Date:
2025-09-23
Last Update Post Date Type:
ESTIMATED